What is the management for a patient on anticoagulants (blood thinners) who has fallen and hit their head?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Head Trauma in Anticoagulated Patients

Obtain an immediate non-contrast head CT scan for any patient on anticoagulation who has fallen and hit their head, regardless of symptom severity or mechanism of injury. 1

Initial Imaging and Risk Assessment

  • The threshold for initial CT imaging in anticoagulated patients after head trauma is very low because patients on warfarin have a 3.9% risk of significant intracranial injury versus 1.5% in non-anticoagulated patients 1

  • Novel oral anticoagulants (NOACs) like apixaban, rivaroxaban, and dabigatran carry a lower but still elevated risk of intracranial hemorrhage (2.6%) compared to warfarin (10.2%), but both are substantially higher than patients without anticoagulation 1

  • Antiplatelet agents including clopidogrel carry similar bleeding risks and should not be considered safer than anticoagulants in this context 1

  • Aspirin monotherapy, particularly in elderly patients, carries a 4.6% risk of traumatic intracranial hemorrhage after ground-level falls, with 81.5% of these patients taking low-dose 81mg aspirin 2

Management Based on Initial CT Results

If Initial CT Shows Intracranial Hemorrhage:

  • Immediately discontinue the anticoagulant and consult neurosurgery 1, 3

  • For warfarin reversal, administer 4-factor prothrombin complex concentrate (4F-PCC) plus 5mg intravenous vitamin K to achieve INR <1.5 1

  • For apixaban or other factor Xa inhibitors, use andexanet alfa as the specific reversal agent if available; if unavailable, use prothrombin complex concentrate 4, 3

  • Consider activated charcoal if apixaban was ingested within 2-4 hours 4, 3

  • Obtain repeat head CT within 24 hours because anticoagulated patients have a 3-fold increased risk of hemorrhage expansion (26% versus 9% in non-anticoagulated patients) 4, 5

If Initial CT is Negative:

The patient can be safely discharged home without routine repeat imaging or hospital admission, even while on anticoagulation. 1, 4

  • The risk of delayed intracranial hemorrhage after a negative initial CT is very low (0.6-6%) and rarely requires neurosurgical intervention 1, 6

  • A multicenter study of 930 patients on warfarin or clopidogrel with negative initial CT found delayed hemorrhage in only 0.6% of warfarin patients (4 of 687) and 0% of clopidogrel patients (0 of 243), with none requiring neurosurgery 1

  • For patients on NOACs specifically, delayed hemorrhage occurred in only 0.95% (3 of 314 patients), with none requiring neurosurgical intervention 7

  • Routine repeat imaging and observation admission are NOT recommended for neurologically intact patients with negative initial CT 1, 4

Special Considerations for High-Risk Features

Brief observation (4-6 hours) before discharge may be considered for patients with:

  • Age >80 years 4, 6
  • History of loss of consciousness or amnesia 1, 4
  • Glasgow Coma Scale <15 1, 4
  • Concomitant use of multiple anticoagulant/antiplatelet agents 1, 7

Discharge Instructions

Provide clear written discharge instructions that include:

  • Signs and symptoms of delayed hemorrhage (severe headache, confusion, vomiting, weakness, seizures) 1, 4
  • Instructions to return immediately or call 911 if these symptoms develop 3
  • Outpatient referral for fall risk assessment and reassessment of anticoagulation risk/benefit 1, 4

Common Pitfalls to Avoid

  • Failing to obtain initial CT imaging in anticoagulated patients after any head trauma, even with minor mechanisms like ground-level falls 1

  • Unnecessarily admitting patients with negative initial CT for repeat imaging, which increases costs and healthcare-associated complications without improving outcomes 1, 4

  • Discontinuing anticoagulation without considering the indication, as the thromboembolic risk may outweigh the small risk of delayed hemorrhage 4, 6, 3

  • Using PT/INR or aPTT to monitor reversal of factor Xa inhibitors, as these tests are not useful for this purpose 3

  • Delaying repeat imaging when neurological deterioration occurs in patients with known intracranial hemorrhage 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2017

Guideline

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Delayed Hemorrhage After Blunt Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.